RA case–control PRS was associated with younger age of RA onset, autoantibody positivity (ACPA and RF), higher disease activity (DAS-C reactive protein, DAS-ESR, Simple Disease Activity Index and DAI), and poorer treatment responses after 24 weeks (BH-FDR<0.10). Here, CRP is linked to rheumatoid arthritis.